FDA Panel Reviews Galleri Multi-Cancer Blood Test: What the Vote Means Estimated read time: 4 minutes On September 23, 2026, the U.S. Food and Drug Administration convened its Molecular and Clinical Genetics Panel to review a premarket approval application for Galleri, a prescription multi-cancer detection blood test made by GRAIL. The meeting was a major
Galleri Cancer Blood Test: What the FDA Panel Vote Means Read More »
Can Mepivacaine Reduce Pain During IUD Placement? Preview Note: A new randomized trial tested a local anesthetic approach to one of the most common concerns about choosing an IUD. The results add useful evidence, but they also raise practical questions about who may benefit and how broadly the findings apply. Estimated read time: 4 minutes. SEO
A randomized trial tested whether mapping and treating low-voltage areas could improve outcomes beyond pulmonary vein isolation in selected adults with persistent atrial fibrillation. The findings are promising but apply to a defined subgroup.
A new FDA approval uses a blood-detected resistance mutation to guide an earlier treatment change in a specific form of advanced breast cancer. Here is what patients should know about the evidence, eligibility, and uncertainties.
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer | Ecura Health Read More »
Researchers identified human antibodies that interrupted key steps in alpha-gal allergic reactions in laboratory tests. The findings may guide future treatment research, but they are not a treatment for patients today.
Alpha-Gal Syndrome Antibodies: What New Research Found | Ecura Health Read More »
You may have seen reports about a fungus called Candida auris, or C. auris, spreading in healthcare facilities and becoming increasingly resistant to antifungal medications. That can sound alarming, especially because Candida is also the name of the yeast associated with common conditions such as vaginal yeast infections and oral thrush. But Candida auris is
Candida Auris: What to Know About This Drug-Resistant Fungus Read More »
Pancreatic cancer remains one of the most difficult cancers to treat, particularly once it has spread to other parts of the body. But a new investigational drug called daraxonrasib is generating significant interest after results from a large Phase III clinical trial showed substantially longer survival compared with standard chemotherapy in people with previously treated
You’re Not Too Young for Rectal Cancer For many years, rectal cancer was considered a disease that primarily affected older adults. That assumption is no longer true. Over the past two decades, doctors have seen a steady increase in rectal and colorectal cancer among people in their 20s, 30s, and 40s. Many of these individuals
You’re Not Too Young for Rectal Cancer Read More »
New Study Links Vitamins A and D to Better Lung Health in People With Asthma Published July 2026 A new study suggests that vitamins A and D may play an important role in lung health for people living with asthma. Researchers found that higher blood levels of these vitamins were associated with better lung function,
Vitamins A and D to Better Lung Health in Asthmatics Read More »
Retatrutide Delivers Remarkable Weight Loss in Landmark Phase 3 Trial Published: June 2026 A new investigational obesity medication may represent the next major breakthrough in weight management. Eli Lilly recently announced results from the Phase 3 TRIUMPH-1 clinical trial showing that retatrutide, an experimental once-weekly injection, produced average weight loss approaching 30% of body
Retatrutide Trial 3 Results Read More »
